Table 1: European Community Recommendations for Blood and Bone Marrow Transplantation regarding the diagnosis of SARS-CoV-2.
EBMT Reccomendation |
Recipient: · COVID-19 Diagnosis: o High risk disease : HCT should be postponed until the patient is asymptomatic and shows three repeat viral PCR negative results at least one week apart. o Low risk disease : It is recommended to postpone HCT for three months · Respiratory Tract Infection o Test for respiratory viruses by multiplex PCR and depending on which virus is detected, delaying HCT should be considered · Close contact with confirmed COVID-19 o Any transplant procedure should be delayed until at least 14 and preferably 21 days from last contact o Strict monitoring for the presence of COVID-19 using PCR · All HCT recipients should refrain from unnecessary travel to areas designated as high risk by the WHO |
Source: European Society for Blood And Marrow Transplant. COVID-19 and BMT. 2020